As of 2024-12-13, the EV/EBITDA ratio of Hollister Biosciences Inc (HOLL.CN) is
4.80.
EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HOLL.CN's latest enterprise value
is 35.14 mil CAD. HOLL.CN's TTM EBITDA according to its financial statements is
7.32 mil CAD. Dividing these 2
quantities gives us the above HOLL.CN EV/EBITDA ratio.
|
Range |
Selected |
| Trailing P/E multiples |
34.6x - 50.3x |
42.4x |
| Forward P/E multiples |
25.4x - 36.3x |
30.8x |
| Fair Price |
0.99 - 1.94 |
1.42 |
| Upside |
581.7% - 1241.0% |
880.6% |